Clinical-stage biotherapeutics company developing drug-device products for cardiopulmonary and cardiac diseases
Clinical-stage biotherapeutics company developing drug-device products for cardiopulmonary and cardiac diseases. Its INOpulse platform delivers inhaled nitric oxide through a portable device, with programs targeting pulmonary arterial hypertension and pulmonary hypertension associated with COPD and interstitial lung disease.